Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-2 of 2
Keywords: Kardiotoxizität
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Oncology
Journal:
Kompass Onkologie
Kompass Onkol (2014) 1 (2): 90–91.
Published Online: 01 October 2014
... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Anthrazykline Kardiotoxizität Chemotherapie Herzerkrankung...
Journal Articles
Subject Area:
Oncology
Journal:
Kompass Onkologie
Kompass Onkol (2014) 1 (2): 84–85.
Published Online: 01 October 2014
... als auch Anthrazyklin mit Kardiotoxizität verbunden; bisher ist nicht geklärt, wie Trastuzumab in Kombination mit einem Anthrazyklin einzusetzen ist, um die Kardiotoxizität zu minimieren. Patientinnen und Methoden: Zwischen 2010 und 2013 behandelten wir 41 Patientinnen mit Her2-positivem Mammakarzinom...